Aldámiz-Echevarria Teresa, Fanciulli Chiara, Lopez Mónica, Perez Leire, Tejerina Francisco, Sanchez David, Lodeiros Blanca, López Juan Carlos, Berenguer Juan, Bellon Jose Maria, Ferris Maria, Blazquez Mario, Calvo Almudena, Domene Mario, Vegas Oswaldo, Rodriguez Carmen, Muñoz Patricia, Gijon Paloma, Montilla Pedro, Bermudez Elena, Valerio Maricela, Alonso Roberto, Padilla Belen, Ventimilla Critina, Diez Cristina
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Sci Rep. 2025 Jan 28;15(1):3583. doi: 10.1038/s41598-025-86540-8.
With the aim of improving access and engagement to healthcare in people living with HIV (PLHIV), in 2022 Gregorio Marañón Hospital and the NGO COGAM developed a circuit for recruitment and referral to hospital. Program targeted PLHIV who were neither receiving antiretroviral treatment (ART) nor on medical follow-up (FU); but also, individuals at risk who underwent screening tests at the NGO and, if positive, were referred for confirmation. The result was an increase in annual new PLHIV seen in hospital by reaching a population who were, essentially, young men (94% male, median age 30 years), migrants (95%) with recent diagnosis of HIV (median 5 years) and who were recently arrived in Spain (median 5 months). Most of them hadn´t healthcare coverage (78%). In multivariate analysis, that included all PLHIV seen for the first time in the ID Unit between 2019 and 2022, lack of healthcare coverage was the only independent predictor of lost to FU that reached statistical significance (HR 5.19, CI 2.76-9.47). Furthermore, time from HIV diagnosis to ART initiating was shortened from 14 to 6 days without affecting linkage to care. Our conclusion is that collaboration with NGOs reinforce diagnosis, FU, and adherence to ART for PLHIV.
为了改善艾滋病毒感染者（PLHIV）获得医疗保健服务的机会并提高其参与度，2022年，格雷戈里奥·马拉尼翁医院与非政府组织COGAM合作开发了一个医院招募和转诊流程。该项目的目标人群包括未接受抗逆转录病毒治疗（ART）且未接受医学随访（FU）的艾滋病毒感染者；此外，还包括在该非政府组织接受筛查检测的高危人群，检测呈阳性者会被转诊以进行确诊。结果是，医院每年新接诊的艾滋病毒感染者数量有所增加，这些感染者主要是年轻男性（94%为男性，中位年龄30岁）、移民（95%），近期确诊感染艾滋病毒（中位确诊时间5年），且最近刚抵达西班牙（中位抵达时间5个月）。他们中的大多数人没有医保覆盖（78%）。在多变量分析中，纳入了2019年至2022年期间在感染科首次就诊的所有艾滋病毒感染者，缺乏医保覆盖是失访的唯一具有统计学意义的独立预测因素（风险比5.19，置信区间2.76 - 9.47）。此外，从艾滋病毒诊断到开始接受抗逆转录病毒治疗的时间从14天缩短至6天，且不影响与医疗服务的衔接。我们的结论是，与非政府组织的合作加强了艾滋病毒感染者的诊断、随访以及对抗逆转录病毒治疗的依从性。
